Stoke Therapeutics Inc. has granted stock options to purchase a total of 195,800 shares of common stock to ten new employees. The options have an exercise price of $35.60 per share, matching the company's closing stock price on September 15, 2025. Each option will vest over four years, with one quarter of the shares vesting on the first anniversary of the grant date and the remaining shares vesting monthly over the subsequent three years. The options have a ten-year term and are subject to the terms of the 2023 Inducement Plan and the corresponding stock option agreements.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251016067722) on October 16, 2025, and is solely responsible for the information contained therein.